First Trust Advisors LP Has $216,000 Stock Position in Envista Holdings Co. (NYSE:NVST)

First Trust Advisors LP decreased its stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 97.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,220 shares of the company's stock after selling 363,165 shares during the quarter. First Trust Advisors LP's holdings in Envista were worth $216,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Envista during the 4th quarter worth approximately $53,000. Lecap Asset Management Ltd. acquired a new position in shares of Envista during the 4th quarter worth approximately $281,000. Hantz Financial Services Inc. increased its position in shares of Envista by 146.6% during the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company's stock worth $2,131,000 after purchasing an additional 65,679 shares during the last quarter. Norges Bank acquired a new position in shares of Envista during the 4th quarter worth approximately $38,052,000. Finally, Natixis Advisors LLC boosted its stake in shares of Envista by 1.8% during the 4th quarter. Natixis Advisors LLC now owns 106,652 shares of the company's stock worth $2,057,000 after acquiring an additional 1,845 shares during the period.

Envista Price Performance

Shares of NYSE:NVST traded up $0.11 during trading on Friday, reaching $18.20. 223,026 shares of the company traded hands, compared to its average volume of 2,525,952. The company's 50 day moving average is $16.50 and its two-hundred day moving average is $18.98. The firm has a market capitalization of $3.08 billion, a PE ratio of -2.80, a PEG ratio of 1.27 and a beta of 0.97. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 52 week low of $14.22 and a 52 week high of $23.00.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The firm had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The company's revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.26 EPS. As a group, sell-side analysts predict that Envista Holdings Co. will post 1 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Bank of America reduced their target price on Envista from $26.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Piper Sandler reduced their target price on Envista from $18.00 to $17.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Needham & Company LLC restated a "hold" rating on shares of Envista in a research note on Thursday, March 6th. UBS Group reduced their price target on Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Finally, Jefferies Financial Group boosted their price target on Envista from $20.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $20.08.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.